| Abbvie (3) |  |
| Alkaloid (11) | |
| Allergan (6) | |
| Astrazeneca (7) | |
| Basi (302) | |
| Bayer (10) | |
| Eisai company (3) | |
| Emergent biosolutions (4) | |
| F hoffmann la roche ltd (24) | |
| Glaxosmithkline (15) | |
| Merck & co (4) | |
| Novartis (22) | |
| Pfizer (10) | |
| Regeneron pharmaceuticals (3) | |
| Sanofi (5) | |
and neutralize Marburg virushich has a mortality rate of up to 90%ere developed through an academic-industrial partnership including TSRI, Integrated Biotherapeutics, Mapp Biopharmaceutical and Emergent biosolutions.
In the new study, TSRI researchers designed proteins which elicited new antibodies developed at Emergent biosolutions.
and evaluate the antibodies point the way forward, added Jody Berry, the former Director of Pipeline Research of Emergent biosolutions,
current director of pipeline research of Emergent biosolutions. here are multiple filoviruses that threaten our communities, front line medical workers and defense personnel,
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011